カテゴリー： QYResearch, 世界

自己免疫性肝炎治療の世界市場：規模・現状・予測

◆英語タイトル：Global Autoimmune Hepatitis Treatment Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18186
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：99
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、自己免疫性肝炎治療の世界市場について調査・分析し、自己免疫性肝炎治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（テーブル製品、インジェクト製品、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の自己免疫性肝炎治療市場動向
・主要企業別マーケットシェア
・自己免疫性肝炎治療の種類別市場規模2014-2019
（テーブル製品、インジェクト製品、その他）
・自己免疫性肝炎治療の用途別市場規模2014-2019
（病院、クリニック、その他）
・自己免疫性肝炎治療の北米市場：主要企業・種類別/用途別市場規模
・自己免疫性肝炎治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・自己免疫性肝炎治療の中国市場：主要企業・種類別/用途別市場規模
・自己免疫性肝炎治療の日本国内市場：主要企業・種類別/用途別市場規模
・自己免疫性肝炎治療の東南アジア市場：主要企業・種類別/用途別市場規模
・自己免疫性肝炎治療のインド市場：主要企業・種類別/用途別市場規模
・自己免疫性肝炎治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Gilead Sciences, Inc.、Acorda Therapeutics, Inc.、Allergan & Novartis、Intercept Pharmaceuticals, Inc.、Hightidetx、Shire Plc.、NGM Biopharmaceuticals, Inc.、EA Pharma、BiomX、CymaBay Therapeutics、Conatus Pharmaceuticals, Inc.、Durect Corporation、Sirnaomics, Inc.、Shenzhen HighTide Biopharmaceuticals Ltd.）
・自己免疫性肝炎治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

Autoimmune Hepatitis is a serious condition that may worsen over time if not treated. Autoimmune Hepatitis can lead to cirrhosis and liver failure.Autoimmune hepatitis is a disease in which the body’s own immune system attacks the liver and causes it to become inflamed.In 2018, the global Autoimmune Hepatitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Autoimmune Hepatitis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Autoimmune Hepatitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Gilead Sciences, Inc.
Acorda Therapeutics, Inc.
Allergan & Novartis
Intercept Pharmaceuticals, Inc.
Hightidetx
Shire Plc.
NGM Biopharmaceuticals, Inc.
EA Pharma
BiomX
CymaBay Therapeutics
Conatus Pharmaceuticals, Inc.
Durect Corporation
Sirnaomics, Inc.
Shenzhen HighTide Biopharmaceuticals Ltd.

Market segment by Type, the product can be split into
Table Product
Inject Product
Others

Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Autoimmune Hepatitis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Autoimmune Hepatitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Autoimmune Hepatitis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Table Product
1.4.3 Inject Product
1.4.4 Others
1.5 Market by Application
1.5.1 Global Autoimmune Hepatitis Treatment Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Autoimmune Hepatitis Treatment Market Size
2.2 Autoimmune Hepatitis Treatment Growth Trends by Regions
2.2.1 Autoimmune Hepatitis Treatment Market Size by Regions (2019-2025)
2.2.2 Autoimmune Hepatitis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Autoimmune Hepatitis Treatment Market Size by by Players
3.1.1 Global Autoimmune Hepatitis Treatment Revenue by by Players (2014-2019)
3.1.2 Global Autoimmune Hepatitis Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Autoimmune Hepatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Autoimmune Hepatitis Treatment Key Players Head office and Area Served
3.3 Key Players Autoimmune Hepatitis Treatment Product/Solution/Service
3.4 Date of Enter into Autoimmune Hepatitis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Autoimmune Hepatitis Treatment Market Size by Type (2014-2019)
4.2 Global Autoimmune Hepatitis Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Autoimmune Hepatitis Treatment Market Size (2014-2019)
5.2 Autoimmune Hepatitis Treatment Key Players in North America
5.3 North America Autoimmune Hepatitis Treatment Market Size by Type
5.4 North America Autoimmune Hepatitis Treatment Market Size by Application

6 Europe
6.1 Europe Autoimmune Hepatitis Treatment Market Size (2014-2019)
6.2 Autoimmune Hepatitis Treatment Key Players in Europe
6.3 Europe Autoimmune Hepatitis Treatment Market Size by Type
6.4 Europe Autoimmune Hepatitis Treatment Market Size by Application

7 China
7.1 China Autoimmune Hepatitis Treatment Market Size (2014-2019)
7.2 Autoimmune Hepatitis Treatment Key Players in China
7.3 China Autoimmune Hepatitis Treatment Market Size by Type
7.4 China Autoimmune Hepatitis Treatment Market Size by Application

8 Japan
8.1 Japan Autoimmune Hepatitis Treatment Market Size (2014-2019)
8.2 Autoimmune Hepatitis Treatment Key Players in Japan
8.3 Japan Autoimmune Hepatitis Treatment Market Size by Type
8.4 Japan Autoimmune Hepatitis Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Autoimmune Hepatitis Treatment Market Size (2014-2019)
9.2 Autoimmune Hepatitis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Autoimmune Hepatitis Treatment Market Size by Type
9.4 Southeast Asia Autoimmune Hepatitis Treatment Market Size by Application

10 India
10.1 India Autoimmune Hepatitis Treatment Market Size (2014-2019)
10.2 Autoimmune Hepatitis Treatment Key Players in India
10.3 India Autoimmune Hepatitis Treatment Market Size by Type
10.4 India Autoimmune Hepatitis Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Autoimmune Hepatitis Treatment Market Size (2014-2019)
11.2 Autoimmune Hepatitis Treatment Key Players in Central & South America
11.3 Central & South America Autoimmune Hepatitis Treatment Market Size by Type
11.4 Central & South America Autoimmune Hepatitis Treatment Market Size by Application

12 International Players Profiles
12.1 Gilead Sciences, Inc.
12.1.1 Gilead Sciences, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Autoimmune Hepatitis Treatment Introduction
12.1.4 Gilead Sciences, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2014-2019))
12.1.5 Gilead Sciences, Inc. Recent Development
12.2 Acorda Therapeutics, Inc.
12.2.1 Acorda Therapeutics, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Autoimmune Hepatitis Treatment Introduction
12.2.4 Acorda Therapeutics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2014-2019)
12.2.5 Acorda Therapeutics, Inc. Recent Development
12.3 Allergan & Novartis
12.3.1 Allergan & Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Autoimmune Hepatitis Treatment Introduction
12.3.4 Allergan & Novartis Revenue in Autoimmune Hepatitis Treatment Business (2014-2019)
12.3.5 Allergan & Novartis Recent Development
12.4 Intercept Pharmaceuticals, Inc.
12.4.1 Intercept Pharmaceuticals, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Autoimmune Hepatitis Treatment Introduction
12.4.4 Intercept Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2014-2019)
12.4.5 Intercept Pharmaceuticals, Inc. Recent Development
12.5 Hightidetx
12.5.1 Hightidetx Company Details
12.5.2 Company Description and Business Overview
12.5.3 Autoimmune Hepatitis Treatment Introduction
12.5.4 Hightidetx Revenue in Autoimmune Hepatitis Treatment Business (2014-2019)
12.5.5 Hightidetx Recent Development
12.6 Shire Plc.
12.6.1 Shire Plc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Autoimmune Hepatitis Treatment Introduction
12.6.4 Shire Plc. Revenue in Autoimmune Hepatitis Treatment Business (2014-2019)
12.6.5 Shire Plc. Recent Development
12.7 NGM Biopharmaceuticals, Inc.
12.7.1 NGM Biopharmaceuticals, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Autoimmune Hepatitis Treatment Introduction
12.7.4 NGM Biopharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2014-2019)
12.7.5 NGM Biopharmaceuticals, Inc. Recent Development
12.8 EA Pharma
12.8.1 EA Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Autoimmune Hepatitis Treatment Introduction
12.8.4 EA Pharma Revenue in Autoimmune Hepatitis Treatment Business (2014-2019)
12.8.5 EA Pharma Recent Development
12.9 BiomX
12.9.1 BiomX Company Details
12.9.2 Company Description and Business Overview
12.9.3 Autoimmune Hepatitis Treatment Introduction
12.9.4 BiomX Revenue in Autoimmune Hepatitis Treatment Business (2014-2019)
12.9.5 BiomX Recent Development
12.10 CymaBay Therapeutics
12.10.1 CymaBay Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Autoimmune Hepatitis Treatment Introduction
12.10.4 CymaBay Therapeutics Revenue in Autoimmune Hepatitis Treatment Business (2014-2019)
12.10.5 CymaBay Therapeutics Recent Development
12.11 Conatus Pharmaceuticals, Inc.
12.12 Durect Corporation
12.13 Sirnaomics, Inc.
12.14 Shenzhen HighTide Biopharmaceuticals Ltd.

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Autoimmune Hepatitis Treatment Key Market Segments
Table Key Players Autoimmune Hepatitis Treatment Covered
Table Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Table Product Figures
Table Key Players of Table Product
Figuer Inject Product Figures
Table Key Players of Inject Product
Figuer Others Figures
Table Key Players of Others
Table Global Autoimmune Hepatitis Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Autoimmune Hepatitis Treatment Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Autoimmune Hepatitis Treatment Report Years Considered
Figure Global Autoimmune Hepatitis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Autoimmune Hepatitis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Autoimmune Hepatitis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Autoimmune Hepatitis Treatment Market Share by Regions 2014-2019
Figure Global Autoimmune Hepatitis Treatment Market Share by Regions 2014-2019
Figure Global Autoimmune Hepatitis Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Autoimmune Hepatitis Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Autoimmune Hepatitis Treatment Market Share by by Players (2014-2019)
Figure Global Autoimmune Hepatitis Treatment Market Share by by Players in 2018
Table Global Autoimmune Hepatitis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Autoimmune Hepatitis Treatment Product/Solution/Service
Table Date of Enter into Autoimmune Hepatitis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Autoimmune Hepatitis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Autoimmune Hepatitis Treatment Market Size Share by Type (2014-2019)
Figure Global Autoimmune Hepatitis Treatment Market Size Market Share by Type (2014-2019)
Table Global Autoimmune Hepatitis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Autoimmune Hepatitis Treatment Market Size Share by Application (2014-2019)
Figure Global Autoimmune Hepatitis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Autoimmune Hepatitis Treatment Revenue Market Share by Application in 2018
Figure North America Autoimmune Hepatitis Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Autoimmune Hepatitis Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Autoimmune Hepatitis Treatment Market Share (2018-2019)
Table North America Autoimmune Hepatitis Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Autoimmune Hepatitis Treatment Market Share by Type 2014-2019
Table North America Autoimmune Hepatitis Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Autoimmune Hepatitis Treatment Market Share by Application 2014-2019
Figure Europe Autoimmune Hepatitis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Autoimmune Hepatitis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Autoimmune Hepatitis Treatment Market Share (2018-2019)
Table Europe Autoimmune Hepatitis Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Autoimmune Hepatitis Treatment Market Share by Type 2014-2019
Table Europe Autoimmune Hepatitis Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Autoimmune Hepatitis Treatment Market Share by Application 2014-2019
Figure China Autoimmune Hepatitis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Autoimmune Hepatitis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Autoimmune Hepatitis Treatment Market Share (2018-2019)
Table China Autoimmune Hepatitis Treatment Market Size by Type 2014-2019 (Million US$)
Table China Autoimmune Hepatitis Treatment Market Share by Type 2014-2019
Table China Autoimmune Hepatitis Treatment Market Size by Application 2014-2019 (Million US$)
Table China Autoimmune Hepatitis Treatment Market Share by Application 2014-2019
Figure Japan Autoimmune Hepatitis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Autoimmune Hepatitis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Autoimmune Hepatitis Treatment Market Share (2018-2019)
Table Japan Autoimmune Hepatitis Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Autoimmune Hepatitis Treatment Market Share by Type 2014-2019
Table Japan Autoimmune Hepatitis Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Autoimmune Hepatitis Treatment Market Share by Application 2014-2019
Figure Southeast Asia Autoimmune Hepatitis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Autoimmune Hepatitis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Autoimmune Hepatitis Treatment Market Share (2018-2019)
Table Southeast Asia Autoimmune Hepatitis Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Autoimmune Hepatitis Treatment Market Share by Type 2014-2019
Table Southeast Asia Autoimmune Hepatitis Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Autoimmune Hepatitis Treatment Market Share by Application 2014-2019
Figure India Autoimmune Hepatitis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Autoimmune Hepatitis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Autoimmune Hepatitis Treatment Market Share (2018-2019)
Table India Autoimmune Hepatitis Treatment Market Size by Type 2014-2019 (Million US$)
Table India Autoimmune Hepatitis Treatment Market Share by Type 2014-2019
Table India Autoimmune Hepatitis Treatment Market Size by Application 2014-2019 (Million US$)
Table India Autoimmune Hepatitis Treatment Market Share by Application 2014-2019
Figure Central & South America Autoimmune Hepatitis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Autoimmune Hepatitis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Autoimmune Hepatitis Treatment Market Share (2018-2019)
Table Central & South America Autoimmune Hepatitis Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Autoimmune Hepatitis Treatment Market Share by Type 2014-2019
Table Central & South America Autoimmune Hepatitis Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Autoimmune Hepatitis Treatment Market Share by Application 2014-2019
Table Gilead Sciences, Inc. Company Details
Table Gilead Sciences, Inc. Revenue in Autoimmune Hepatitis Treatment Business 2014-2019 (Million US$)
Figure Gilead Sciences, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2014-2019)
Table Gilead Sciences, Inc. Recent Development
Table Acorda Therapeutics, Inc. Company Details
Table Acorda Therapeutics, Inc. Revenue in Autoimmune Hepatitis Treatment Business 2014-2019 (Million US$)
Figure Acorda Therapeutics, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2014-2019)
Table Acorda Therapeutics, Inc. Recent Development
Table Allergan & Novartis Company Details
Table Allergan & Novartis Revenue in Autoimmune Hepatitis Treatment Business 2014-2019 (Million US$)
Figure Allergan & Novartis Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2014-2019)
Table Allergan & Novartis Recent Development
Table Intercept Pharmaceuticals, Inc. Company Details
Table Intercept Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business 2014-2019 (Million US$)
Figure Intercept Pharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2014-2019)
Table Intercept Pharmaceuticals, Inc. Recent Development
Table Hightidetx Company Details
Table Hightidetx Revenue in Autoimmune Hepatitis Treatment Business 2014-2019 (Million US$)
Figure Hightidetx Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2014-2019)
Table Hightidetx Recent Development
Table Shire Plc. Company Details
Table Shire Plc. Revenue in Autoimmune Hepatitis Treatment Business 2014-2019 (Million US$)
Figure Shire Plc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2014-2019)
Table Shire Plc. Recent Development
Table NGM Biopharmaceuticals, Inc. Company Details
Table NGM Biopharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business 2014-2019 (Million US$)
Figure NGM Biopharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2014-2019)
Table NGM Biopharmaceuticals, Inc. Recent Development
Table EA Pharma Company Details
Table EA Pharma Revenue in Autoimmune Hepatitis Treatment Business 2014-2019 (Million US$)
Figure EA Pharma Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2014-2019)
Table EA Pharma Recent Development
Table BiomX Company Details
Table BiomX Revenue in Autoimmune Hepatitis Treatment Business 2014-2019 (Million US$)
Figure BiomX Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2014-2019)
Table BiomX Recent Development
Table CymaBay Therapeutics Company Details
Table CymaBay Therapeutics Revenue in Autoimmune Hepatitis Treatment Business 2014-2019 (Million US$)
Figure CymaBay Therapeutics Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2014-2019)
Table CymaBay Therapeutics Recent Development
Table Conatus Pharmaceuticals, Inc. Company Details
Table Durect Corporation Company Details
Table Sirnaomics, Inc. Company Details
Table Shenzhen HighTide Biopharmaceuticals Ltd. Company Details
Table Global Autoimmune Hepatitis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Autoimmune Hepatitis Treatment Market Size Share by Regions (2019-2025)
Figure Global Autoimmune Hepatitis Treatment Market Size Share by Regions in 2025
Figure North America Autoimmune Hepatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Autoimmune Hepatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Autoimmune Hepatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Autoimmune Hepatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Autoimmune Hepatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Autoimmune Hepatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Autoimmune Hepatitis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Autoimmune Hepatitis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Autoimmune Hepatitis Treatment Market Size by Product (2019-2025)
Figure Global Autoimmune Hepatitis Treatment Market Size by Product in 2025
Table Global Autoimmune Hepatitis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Autoimmune Hepatitis Treatment Market Size by Application (2019-2025)
Figure Global Autoimmune Hepatitis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Gilead Sciences, Inc.、Acorda Therapeutics, Inc.、Allergan & Novartis、Intercept Pharmaceuticals, Inc.、Hightidetx、Shire Plc.、NGM Biopharmaceuticals, Inc.、EA Pharma、BiomX、CymaBay Therapeutics、Conatus Pharmaceuticals, Inc.、Durect Corporation、Sirnaomics, Inc.、Shenzhen HighTide Biopharmaceuticals Ltd.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 自己免疫性肝炎治療の世界市場：規模・現状・予測(Global Autoimmune Hepatitis Treatment Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp